Journals / MN Kardiyoloji / 2014 / Cilt: 21 - Sayı: 3

The importance of tricuspid valve in mitral valve diseases

Mitral kapak hastalıklarında triküspid kapağın önemi

Pages
176–181
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It must be known that tricuspid valves are as important as left sided valves, and effective in terms of survival of the patient and life standard.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Valvular heart diseases occur commonly in developing countries.
📊
Key Findings & Data:In our country, the prevelance of rheumatismal heart disease is 0.37%.
💡
Conclusion & Impact:It must be known that tricuspid valves are as important as left sided valves, and effective in terms of survival of the patient and life standard.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Valvular heart diseases occur commonly in developing countries. In our country, the prevelance of rheumatismal heart disease is 0.37%. Left sided rheumatismal heart disease occur more than that of tricuspid valves. So, clinicians and also surgeons may disregard tricuspid valves. Adequate and on time interventions can prevent unnecessary reoperations. Diminution in mortality and morbidity may be achieved. It must be known that tricuspid valves are as important as left sided valves, and effective in terms of survival of the patient and life standard.

Özet

Kalp kapak hastalıkları gelişmekte olan ülkelerde yaygın olarak görülmektedir. Ülkemizde ise romatizmal kalp hastalığının prevelansı binde 3,7’dir. Sol sistem romatizmal kalp kapak hastalıkları triküspid kapaklara göre daha sık görülür. Bu yüzden gerek klinisyenler ge- rekse cerrahlar triküspid kapakları sıklıkla göz ardı edebilmektedirler. Yeterli ve zamanında yapılan müdahaleler ile gereksiz reope- rasyonlar engellenmiş olunur. Mortalite ve morbiditede anlamlı düşüşler sağlanır. Triküspid kapakların en az sol sistem kapaklar ka- dar önemli olduğu, hastanın sağ kalımı ve yaşam standartları açısından da etkili olduğu bilinmelidir.

🔖

Cite This Article

ŞİMŞEK, E., ULUS, T. (2014). The importance of tricuspid valve in mitral valve diseases. MN Kardiyoloji, Cilt: 21 - Sayı: 3, 176–181. https://ajindex.com/articles/297310

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cheitlin MD, Zipes DP. Cardiovascular disease in the eld- erly, Braunwald E, Zipes DP, Libby P, Heart Disease A Textbook of Cardiovascular Medicine, 6th edition, W.B. Saunders Company, Philadelphia 2001;2019-37
  2. Heper C. Valvüler Kalp Hastalıkları http://www.geoci- ties.ws/jaberi20/valv-kalp-h.htm (Erişim tarihi: 31.07.2013
  3. Roberts WC, Perloff JK. Mitral valvular disease: a clinico- pathologic survey of the conditions causing the mitral valve to function abnormally. Ann Intern Med 1972;77: 939-75
  4. Rusted IE, Scheifley CH, Edwards JE. Studies of the mitral valve, II: certain anatomic features of the mitral valve and associated structures in mitral stenosis. Circulation 1956;14:398-406
  5. Hugenholtz PG, Ryan TJ, Stein SW, Belmann WH. The spectrum of pure mitral stenosis: hemodynamic studies in relation to clinical disability. Am J Cardiol 1962;10: 773-84
  6. Rowe JC, Bland EF, Sprague HB, White PD. The course of mitral stenosis without surgery: ten- and twenty-year perspectives. Ann Intern Med 1960;52:741-9
  7. Olesen KH. The natural history of 271 patients with mi- tral stenosis under medical treatment. Br Heart J 1962;24:349-57
  8. Selzer A, Cohn KE. Natural history of mitral stenosis: a re- view. Circulation 1972;45:878-90
  9. Dubin AA, March HW, Cohn K, Selzer A. Longitudinal he- modynamic and clinical study of mitral stenosis. Circulation 1971;44:381-9
  10. Gordon SP, Douglas PS, Come PC, Manning WJ. Two-di- mensional and Doppler echocardiographic determinants of the natural history of mitral valve narrowing in pa- tients with rheumatic mitral stenosis: implications for fol- low-up. J Am Coll Cardiol 1992;19:968-73
  11. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardio- vascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:523-661
  12. Helmut Baumgartner, Jeroen Bax, Eric Butchart, et al. Guidelines on the management of valvular heart disease. European Heart Journal 2007;28:230-68 13. Enriquez-Sarano M, Freeman WK, Tribouilloy CM, et al. Functional anatomy of mitral regurgitation: accurac